| Logo | Name | Σ | Employees |
|---|---|---|---|
 |  Leads To Development Your expert drug development partner, guiding your asset to and through the clinic If you’ve only got one shot at getting your drug to the clinic, we’ll help you make it the best one. At Leads to Development, we enable biotech companies to bring novel drugs to and through clinical trials as efficiently and smoothly as possible. With decades of experience and more than 160 projects under our belt throughout Europe and the US, our team provides comprehensive end-to-end support across all areas of new drug development. Our backgrounds are in biotech rather than big pharma, so we understand the … 109 similar entities Type: SMB Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 18 |
 | Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, MASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … 85 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 271 |
 |  Discovery Park A thriving life science community for entrepreneurs and leaders and the ideal environment for businesses to succeed 🧪 Discovery Park is the ideal environment for life science businesses to succeed. From state-of-the-art labs and offices to comprehensive support, we work in partnership with you to provide firm foundations for every stage of your growth. Within easy reach of London, our location provides access to a wealth of resources and opportunities with the freedom to expand, making it the optimal setting for brilliant minds to unlock the potential of scientific breakthroughs. Science, Technology, Manufacturing, Research , Research and Development, Enterprise, Logistics, … 75 similar entities Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology | 24 | 79 |
 | Sygnature Discovery North America Enabling Success Sygnature Discovery, headquartered in Nottingham (UK), is a world-leading contract research organization for drug discovery. Based in the UK (Nottingham, Alderley Park, Macclesfield, Glasgow) and Canada (Montreal, Laval, Quebec) and with a staff of over 1,000, including over 900 scientists, Sygnature Discovery partners with the global pharmaceutical industry, biotechs and NfP organizations wishing to outsource part of their R&D work. Since 2004, Sygnature Discovery has delivered more than 56 new preclinical compounds, 29 clinical compounds and 1 registered, thanks to the talents of its world-class scientists, who are named on more than 500 patents. The services offered to … 59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 218 |
 | BIOSYNEX Diagnostics Innovation for Biotherapies BIOSYNEX was founded in 2005 and is one of the most significant European manufacturers and provider of rapid membrane tests in the in-vitro diagnostic market. By staying close to our customers and business partners we are aware of the needs and expectations they may have of our products and services. Listening to their voice, together with the help of our Research and Development laboratories in France and our state of the art manufacturing facilities, allows us to identify new applications in rapid testing, develop and launch innovative products and provide high quality services. Our aim is to … 110 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 1 | 78 |
 | Naobios Biomanufacturing services Naobios provides bioprocess development and contract manufacturing services for viral vaccines and viral vectors. The company was acquired by Clean Biologics on March 1st, 2019 and now supports clients for process development and the manufacture of preclinical and clinical batches. 159 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology | 8 | 39 |
 | CliniSciences Group Reagents and instruments for immunology, cell biology and molecular biology. CliniSciences commercialises reagents (antibodies, recombinants, ELISA kits, RNAi, cDNA clones, probes, PCR/qPCR reagents...) to diagnostic and research labs. As very dynamic company, we do our best to be close to our customers' needs in terms of high quality reagents that we propose and in terms of service that we provide (search for a particular antibody, technical support, delivery time, etc.) Our principal assets for better serving you : adaptability, flexibility, reactivity and naturally the competence of the technical specialists at your service. 76 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 70 |
 | DiscoveryOrtho Partners A Technology Development and Advisory Company Focused on Medical Devices/Biologics Strategic Advisory Services for both large & small medical device/biologics companies including acquisition, licensing, distribution, joint venture agreements Market, Scientific and Clinical Due Diligence Services Business development Services for venture capital, private equity, hedge funds and investment banking clients & their portfolio companies and clients Product/Device development Strategic Product Postioning including licensing, distribtution and market positioning New Company Formation 520 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 2 |
 | Biotrains CONNECT COLLABORATE EVOLVE Biotrains is world's leading provider of business conferences, training, managed events and Consulting services for Pharmaceutical, Biotech, Healthcare and Medical Device industry. We at Biotrains recognize that knowledge is power and continuous learning is fundamental for the success of all business and academia. We deliver world-class content and expert knowledge that our clients demand to outshine in their professional roles giving a competitive advantage to their organization. We organize specialized technical events in areas including • Lyophilization/Freeze Drying • Bioprocess Development & Manufacturing • Drug Development, Drug Discovery • Diagnostics & Personalized Medicine • Healthcare, Home Healthcare … 81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 33 |
 | UK Biocentre A market-leading provider of high throughput end-to-end sample processing and storage solutions. At UK Biocentre we strive to use our expertise and collaborative approach to deliver innovative technology and solutions. Established by UK Biobank in 2011, we are a leader in sample management, high-capacity bioprocessing, and storage. We’re a not-for-profit organisation that supports and facilitates large-scale research studies. We enable life-changing research in the academic, pharmaceutical and biotech research communities offering solutions from sample processing and analysis to genomics and long-term sample cold storage. We are committed to consistently driving quality and innovation. Our heritage, deeply rooted in our dedication … 60 similar entities Type: Startup Activities: deeptech Technologies: Data Analytics | 2 | 202 |
 | 3Biotech 3Biotech provides Innovative solutions continuously to create a new future and impact patient outcomes 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and … 68 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology | 2 | 4 |
 |  AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine 574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 1 |
 | CARBOGEN AMCIS BRINGING YOUR SCIENCE TO LIFE CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India). Learn more … 61 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 7 | 718 |
 | Aliri Bioanalysis We deliver data for life > Aliri is committed to solving industry challenges by bringing innovative bioanalysis and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise. Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions. MALDI Imaging, ADME analysis, Mass Spectrometry Imaging, Preclinical services, Molecular Imaging, Biodistribution, … 161 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 9 | 132 |
 | 4P-Pharma Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, … 168 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 31 | 28 |
 | Bionest Partners Bionest Partners is a global consulting firm focused on Pharma, Biotech, Medical Device and Diagnostics that helps clients navigate complex product development issues in order to drive growth, create value and gain competitive advantage. We also offer our expertise and analytic skills to support investors with due diligence assignments in these markets. Bionest consultants are valued strategic partners who have helped more than 250 companies around the world build high-value product portfolios, optimize development approaches and prepare for commercial success. Our track record includes more than 500 successful projects consisting of innovative, creative and differentiated action plans grounded in in-depth … 62 similar entities Type: SMB Activities: healthtech biotech deeptech consulting Technologies: Synthetic Biology | 2 | 34 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … 97 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 170 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry 662 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research 128 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 36 | 373 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … 173 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 611 |
 | IFPMA We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, … Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology | 42 | 71 |
 | Molecular Devices Advancing Discovery Molecular Devices is one of the world’s leading providers of high-performance life science technology. We make advanced scientific discovery possible for academia, pharma, and biotech customers with platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. From cancer to COVID-19, we've contributed to scientific breakthroughs described in over 230,000 peer-reviewed publications. Over 160,000 of our innovative solutions are incorporated into laboratories worldwide, enabling scientists to improve productivity and effectiveness – ultimately accelerating research and the development of new therapeutics. Molecular Devices is headquartered in Silicon Valley, Calif., with best-in-class teams around the globe. Over … 54 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 738 |
 | Batavia Biosciences Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in … 91 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 160 |
 | Generis Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our … 25 similar entities Type: Startup Activities: healthtech spacetech deeptech biotech transporttech Technologies: Synthetic Biology | 94 | 119 |
 | CHEPLAPHARM A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty … 66 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 442 |
 | COMPLIFE GROUP The best Partner to elevate your Business in Health & Personal Care market Complife is a worldwide group, which provides consulting and testing services for cosmetics, food supplements, medical devices, biocides, household products and pharma. Our scientific experts will help you in demonstrating the safety, tolerability and efficacy of products, as well as their chemical and microbiological features. We offer a wide range of analysis and services in the field of microbiology, chemistry, product development, as well as in the regulatory sector, helping you to meet end users’ expectations. Regulatory & Consulting, Pre-clinical studies: in vitro, Analytical chemistry, Microbiology, and … 156 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 166 |
 | Creapharm, a Myonex company Whether your health product is still in research, is entering a clinical trial, or is ready to be marketed, Creapharm, a Myonex company, is a total global partner committed to assisting and supporting a wide range of projects with supply and services from clinical to commercial. With ten locations in the US, Germany, UK & France, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), hospitals, and sites seeking a flexible, comprehensive solution for their project needs. Learn more at www.creapharm.com Clinical Services include: Primary and secondary packaging and labeling Drug sourcing CTRx TM Ancillaries Compounding Pharmaceutical support, … 102 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 14 | 343 |
 | Bioscibex At Bioscibex, we are redefining bioprocessing with innovative single-use bioreactor solutions tailored for modern biologics and cell therapy manufacturing. Our mission is to empower researchers and manufacturers with tools that simplify processes, enhance scalability, and improve efficiency. 260 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology | 3 | 5 |
 | Eurofins Discovery Eurofins Discovery offers you a complete, single-source solution for drug discovery products and services. Eurofins Discovery has supported Drug Discovery research for >40 years. Our partners inspire us to innovate in the pursuit of life-changing cures. We provide our experience, depth, and breadth in the form of innovative testing services and product tools that support researchers as they accelerate the discovery and development of candidate molecules. Our global team of dedicated scientists, information analysts, and client support professionals make this mission possible. Our focus drives us to continually expand our portfolio of testing methods, tools, and services to enable real, … 71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 204 |
 | eXmoor Pharma Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is more than a CDMO—we are your expert partner in cell and gene therapy development. As the only integrated CGT CDMO with embedded consultancy expertise, we support clients at every stage of their journey, from early-phase strategy to GMP manufacturing and commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and … 52 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 77 |
 | Microbiologics The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug … 175 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 358 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … 313 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 131 |
 | Mercodia Expertise that matters Mercodia utilizes its 30+ years of experience as a world-leading manufacturer of cardiometabolic immunoassays to provide tailored bioanalysis solutions for pharma and biotech companies. We specialize in assay development and validation, PK/PD, immunogenicity testing, and biomarker testing, mainly focusing on large molecules, peptides, and oligonucleotide therapeutics in preclinical and clinical development. We are GLP-certified and work in accordance with ICH GCP, EMA, and FDA guidelines. Our team of expert scientists quickly provides reproducible, reliable, and high-quality data that meets regulatory requirements. We prioritize speed and flexibility while delivering cost-effective solutions. Our vision is to improve human health … 140 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 80 |
 | TC BioPharm Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine 208 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 56 |
 | Galactica Biotech Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications 290 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 0 | 1 |
 | Evologic Technologies Make science based biologicals economically feasible Evologic serves innovative companies with reliable contract development and manufacturing capabilities to stabilize and deliver difficult-to-produce microbial products by fermentation. Our customers benefit from our leading-edge scientific expertise in combination with our proprietary manufacturing and formulation technologies enabling the delivery of the trickiest organisms reliably. Our highly talented, EU-based, agile team is the core of our competitive edge enabling us to provide highly concentrated, contaminant-free, and stable products to our customers rapidly. Our customers usually: • have an organism that no-one else can grow • require development of a scalable manufacturing process • want … 68 similar entities Type: Startup Activities: manufacturing deeptech | 1 | 28 |
 | Reshape Biotech Accelerating the pace of R&D. Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on reinventing … 63 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics | 3 | 73 |
 | Icosagen European Mammalian CRDMO - From Discovery mgs to Clinical GMP kgs. We're a leading European biotechnology company, providing streamlined or custom-tailored services for global clients in pharmaceutical, biotechnology industries, and academia. We've been a privately held family business since 1999, and have grown into a leading mammalian Contract Research, Development, and Manufacturing Organization (CRDMO). The CRDMO approach allows us to cover the entire spectrum of pre-clinical and clinical services - from the initial stages of target discovery and development, to cell line development, and manufacturing of mammalian therapeutic proteins, up to 1000 L scale. In 2023, we worked with more … 136 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 148 |
 | Acceleron Pharma Accelerating drug discovery to transform patients' lives Effective 11/22/21, Acceleron Pharma Inc. is now a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (known as MSD outside the United States and Canada) http://merck.com Biopharmaceuticals, Orphan Disease Therapeutics, Rare Diseases, and Serious Diseases 605 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 67 |
 | AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules 550 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 17 |
 | Arctoris Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford, UK. Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner … 52 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 9 | 34 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing 86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 181 |
 | Genewity B.V. Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field. 275 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 14 |
 | AXIOS Senolytics Innovation at the service of your health and well-being. Pharmaceutical company, R & AMP; D dedicated to the development and marketing of senolytic compounds, food supplements and aging medications, age -related degenerative diseases and cancer. 322 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | N/A |
 | Selvita Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening 504 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 771 |
 | Cytovance Biologics We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner. Welcome to Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for clinical … 69 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 199 |
 | Cellomatics Biosciences Ltd Our expertise, Your discovery Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies. Multiplex Immunoassay, Target and biomarker validation, In vitro functional assays, Molecular Biology, Receptor binding, Toxicity testing, Immuno-Oncology, Oncology, Immunology, Inflammation, and Respiratory 376 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 19 |
 | KCAS Bio A contract research organization (CRO) advancing the latest in drug development with leading sponsors, worldwide. KCAS Bio is a top-tier contract research organization (CRO) that has 45 years of experience with both large pharma and biotech sponsors, providing comprehensive bioanalytical drug development services from early discovery through registration. We have supported more than 300+ FDA approved drugs on the market, developed 5,000+ proprietary and non-proprietary assays to date, and undergone 18 FDA audits with no major findings. Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve … 145 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 356 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … 75 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology | 7 | 440 |
 | Nagi Bioscience in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. … 184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 42 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … 71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 33 |
 | Frontage Laboratories, Inc Advancing drug discovery and development through integrated laboratory, analytical, and clinical services Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United … 107 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 671 |
 | NDA Group - an SSI Strategy Company Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is … 123 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 120 |
 | Microtech S.R.L. The logical choice. The microtech was born in 1964 from an idea of the Gaetano Papagno founder. It is based in Naples and specializes in the promotion, sale and distribution of consumer products, reagents and equipment for molecular, mobile, genetic and biochemical biology in all laboratories of the scientific research centers, universities, C.N.R., industries, hospitals and private individuals. The seriousness, commitment and scrupulousness are the principles that distinguish it, which are recognized by both customers and suppliers. For over 40 years our goal has been to create, in central southern Italy, a quality organization that contributes, with its products and … 73 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 30 |
 | Salvat Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos 153 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 380 |
 | Summit Pharmaceuticals International Corporation As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise. 160 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology New Materials | 1 | 34 |
 | Chromodynamics Taking the guesswork out of drug development At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis 250 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 7 |
 | Advanced Instruments, LLC Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for … 76 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 489 |
 | Selexis SA Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, … 142 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 29 |
 | mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … 87 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 1,012 |
 | BioCryst Pharmaceuticals, Inc. We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HAE) and other rare diseases. BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. We are a commercial-stage biotech company with US headquarters in Durham, North Carolina. Our European headquarters is in Dublin, Ireland, and our Discovery Center of Excellence is rooted in Birmingham, Alabama, with many other regional offices … 151 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 611 |
 | Chemglass Life Sciences Where chemistry meets biology. Chemglass was founded in a small garage in Newfield, New Jersey. The year was 1946. Today, Chemglass Life Sciences has grown into a total of 197,000 square feet, in an expansive, three-building complex located in Vineland, NJ. While scientific glassblowing gave us our start, we have expanded to include four major areas of concentration: scientific and OEM glassware manufacture, bioprocess cleanroom assembly, custom metal and plastic machining and electronics design engineering. We serve many markets. Our customers are typically found in the pharmaceutical, biopharmaceutical, and healthcare industries as well as in all levels of academia. Our … 8 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology | 0 | 110 |